These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19790235)

  • 21. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis.
    Yang F; Tuxhorn JA; Ressler SJ; McAlhany SJ; Dang TD; Rowley DR
    Cancer Res; 2005 Oct; 65(19):8887-95. PubMed ID: 16204060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
    Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
    Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines.
    Cronauer MV; Schulz WA; Ackermann R; Burchardt M
    Int J Oncol; 2005 Apr; 26(4):1033-40. PubMed ID: 15753999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of androgen receptor and β-catenin activity in prostate cancer.
    Lee E; Madar A; David G; Garabedian MJ; Dasgupta R; Logan SK
    Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15710-5. PubMed ID: 24019458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
    Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
    J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.
    Deng Q; Tang DG
    Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells.
    Litvinov IV; Vander Griend DJ; Antony L; Dalrymple S; De Marzo AM; Drake CG; Isaacs JT
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15085-90. PubMed ID: 17015840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
    Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
    Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.
    Fan W; Yanase T; Morinaga H; Okabe T; Nomura M; Daitoku H; Fukamizu A; Kato S; Takayanagi R; Nawata H
    J Biol Chem; 2007 Mar; 282(10):7329-38. PubMed ID: 17202144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
    Kokontis JM; Hsu S; Chuu CP; Dang M; Fukuchi J; Hiipakka RA; Liao S
    Prostate; 2005 Dec; 65(4):287-98. PubMed ID: 16015608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular adaptor molecules and AR signalling in the tumour microenvironment.
    Reebye V; Frilling A; Habib NA; Mintz PJ
    Cell Signal; 2011 Jun; 23(6):1017-21. PubMed ID: 21130868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The oncogenic potential of a prostate cancer-derived androgen receptor mutant.
    Shi XB; Xue L; Tepper CG; Gandour-Edwards R; Ghosh P; Kung HJ; DeVere White RW
    Prostate; 2007 May; 67(6):591-602. PubMed ID: 17262801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model.
    Chang HH; Chen BY; Wu CY; Tsao ZJ; Chen YY; Chang CP; Yang CR; Lin DP
    J Biomed Sci; 2011 Jan; 18(1):6. PubMed ID: 21241512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.
    Vummidi Giridhar P; Williams K; VonHandorf AP; Deford PL; Kasper S
    Cancer Res; 2019 Mar; 79(6):1124-1137. PubMed ID: 30626627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stabilizing androgen receptor in mitosis inhibits prostate cancer proliferation.
    Vander Griend DJ; Litvinov IV; Isaacs JT
    Cell Cycle; 2007 Mar; 6(6):647-51. PubMed ID: 17387277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y; Wolff DW; Lin MF; Tu Y
    Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor.
    Nishida S; Hirohashi Y; Torigoe T; Inoue R; Kitamura H; Tanaka T; Takahashi A; Asanuma H; Masumori N; Tsukamoto T; Sato N
    Cancer Sci; 2013 Apr; 104(4):431-6. PubMed ID: 23320511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
    Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
    Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2).
    Liu T; Li Y; Gu H; Zhu G; Li J; Cao L; Li F
    J Biol Chem; 2013 Feb; 288(5):3359-69. PubMed ID: 23132866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.